| Authors: |
Shih BB; Institute for Cancer Genetics, Columbia University, New York, New York, USA., Ma C; Institute for Cancer Genetics, Columbia University, New York, New York, USA., Cortes JR; Institute for Cancer Genetics, Columbia University, New York, New York, USA; Regeneron Pharmaceuticals, Tarrytown, New York, USA., Reglero C; Institute for Cancer Genetics, Columbia University, New York, New York, USA., Miller H; Institute for Cancer Genetics, Columbia University, New York, New York, USA., Quinn SA; Institute for Cancer Genetics, Columbia University, New York, New York, USA., Albero R; Institute for Cancer Genetics, Columbia University, New York, New York, USA; Biomedical Research Institute August Pi y Sunyer (IDIBAPS), Barcelona, Spain., Laurent AP; Institute for Cancer Genetics, Columbia University, New York, New York, USA., Mackey A; Institute for Cancer Genetics, Columbia University, New York, New York, USA., Ferrando AA; Institute for Cancer Genetics, Columbia University, New York, New York, USA; Regeneron Pharmaceuticals, Tarrytown, New York, USA; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA; Department of Pediatrics, Columbia University Medical Center, New York, New York, USA; Department of Systems Biology, Columbia University Medical Center, New York, New York, USA., Geskin L; Department of Medicine, Columbia University Medical Center, New York, New York, USA., Palomero T; Institute for Cancer Genetics, Columbia University, New York, New York, USA; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA. Electronic address: tp2151@cumc.columbia.edu. |
